Polyps – Sue ’ s story
I didn’t in fact end up having a hysterectomy.
I had Polyps removed in December and the biopsy they did then showed Complex Hyperplasia.
I was told by the Consultant to stop the HRT I was on (I take the one that still gives you periods) as I had Complex Hyperplasia and to take some continual form of progesterone, preferably the Myrena Coil and to stop taking any form of oestrogen. I was told categorically by several Consultants that it was the only course of action. I decided against the Myrena Coil as my daughter had had a terrible time when she had one fitted and decided to go with the continued progesterone orally. H...
Source: The Hysterectomy Association - April 7, 2017 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news
Polyps – Sue ’ s story
I didn’t in fact end up having a hysterectomy.
I had Polyps removed in December and the biopsy they did then showed Complex Hyperplasia.
I was told by the Consultant to stop the HRT I was on (I take the one that still gives you periods) as I had Complex Hyperplasia and to take some continual form of progesterone, preferably the Myrena Coil and to stop taking any form of oestrogen. I was told categorically by several Consultants that it was the only course of action. I decided against the Myrena Coil as my daughter had had a terrible time when she had one fitted and decided to go with the continued progesterone orally. H...
Source: The Hysterectomy Association - April 7, 2017 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news
Polyps – Sue ’ s story
I didn’t in fact end up having a hysterectomy.
I had Polyps removed in December and the biopsy they did then showed Complex Hyperplasia.
I was told by the Consultant to stop the HRT I was on (I take the one that still gives you periods) as I had Complex Hyperplasia and to take some continual form of progesterone, preferably the Myrena Coil and to stop taking any form of oestrogen. I was told categorically by several Consultants that it was the only course of action. I decided against the Myrena Coil as my daughter had had a terrible time when she had one fitted and decided to go with the continued progesterone orally. H...
Source: The Hysterectomy Association - April 7, 2017 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news
Polyps – Sue ’ s story
The post Polyps – Sue’s story appeared first on Hysterectomy Association.
I didn’t in fact end up having a hysterectomy.
I had Polyps removed in December and the biopsy they did then showed Complex Hyperplasia.
I was told by the Consultant to stop the HRT I was on (I take the one that still gives you periods) as I had Complex Hyperplasia and to take some continual form of progesterone, preferably the Myrena Coil and to stop taking any form of oestrogen. I was told categorically by several Consultants that it was the only course of action. I decided against the Myrena Coil as my daughter had had a terrible ti...
Source: The Hysterectomy Association - April 7, 2017 Category: OBGYN Authors: Linda Tags: Health Conditions complex hyperplasia polyps Source Type: news
Cancer Facts and Figures: Death Rate Down 25% Since 1991
By Stacy Simon The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society. The cancer death rate for men and women combined fell 25% from its peak in 1991 to 2014, the most recent year for which data are available. This decline translates to more than 2.1 million deaths averted during this time period. “Cancer Statistics, 2017,” published in the American Cancer Society’s journal CA: A Cancer Journal for Clinicians, estimates the numbers of new cancer cases and deaths expected in the US this year. The estimat...
Source: American Cancer Society :: News and Features - January 5, 2017 Category: Cancer & Oncology Tags: General Information Source Type: news
Colorectal cancer prevention: A proven benefit of nonsteroidal anti-inflammatory drugs
The comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements have now been evaluated in preventing the recurrence of advanced neoplasia (polyps that are the precursor of colorectal cancer) after polyp removal. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 20, 2016 Category: Science Source Type: news
Colorectal cancer prevention: A proven benefit of nonsteroidal anti-inflammatory drugs
(Mayo Clinic) Mayo Clinic researchers and a team of collaborating scientists from across the country have determined the comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps that are the precursor of colorectal cancer) after polyp removal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 19, 2016 Category: Global & Universal Source Type: news
Colorectal cancer prevention: A proven benefit of nonsteroidal anti-inflammatory drugs
ROCHESTER, Minn. ? Mayo Clinic researchers and a team of collaborating scientists from across the country have determined the comparative effectiveness of nonsteroidal anti-inflammatory drugs (NSAIDs), aspirin and several supplements in preventing the recurrence of advanced neoplasia (polyps ?that are the precursor of colorectal cancer) after polyp removal. According to the World Cancer Research Fund, [...] (Source: Mayo Clinic Minnesota News)
Source: Mayo Clinic Minnesota News - December 18, 2016 Category: Hospital Management Source Type: news
Lumendi wins FDA 510(k) for DiLumen endoscope positioning accessory
Medical device developer Lumendi said today it won FDA 510(k) clearance for its DiLumen endoscopic accessory.
The Connecticut-based company’s DiLumen device is now indicated for use in positioning endoscopes in the large intestine and assisting with optical visualization, diagnosis and endoscopic treatment.
“DiLumen is the 1st step in a family of devices to enhance endoscopic treatment, including many promising endolumenal therapeutic procedures, that may ultimately improve patient care. Lumendi sees a great potential in endolumenal interventions and is committed to build on this opportunity,” CEO Dr. Pe...
Source: Mass Device - December 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: 510(k) Endoscopic / Arthroscopic Food & Drug Administration (FDA) Regulatory/Compliance Lumendi Source Type: news
MassDevice.com +5 | The top 5 medtech stories for November 15, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Report: Q3 medical device recalls hit highest point since at least 2000
Medical device recalls have reached their highest point since 2000, according to a new report from Stericycle‘s ExpertSolutions business.
Numbers for med...
Source: Mass Device - November 15, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news
Boston Scientific Acquires Resectr(TM) Tissue Resection Device from Distal Access, LLC
MARLBOROUGH, Mass., Nov. 15, 2016 -- (Healthcare Sales & Marketing Network) -- Boston Scientific (BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices.... Devices, Acquisitions Boston Scientific, Distal Access LLC, Resectr , uterine polyps (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 15, 2016 Category: Pharmaceuticals Source Type: news
Boston Scientific buys Resectr tissue resection device from Distal Access
Boston Scientific (NYSE:BSX) said today that it acquired the Resectr tissue resection device from Distal Access for an undisclosed amount.
The buy covers the gynecology and urology portfolio of Salt Lake City-based Distal Access, Boston Scientific said. The Resectr device is designed for polypectomies to remove uterine polyps.
“The Resectr device is exactly the type of innovation we need to help make healthcare more cost-effective and accessible for physicians and their patients,” urology & pelvic health president David Pierce said in prepared remarks. “This acquisition is part of our commitmen...
Source: Mass Device - November 15, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Mergers & Acquisitions Wall Street Beat Women's Health Boston Scientific Distal Access Source Type: news
New blood test for colon cancer screening: Questions remain
In April, the U.S. Food and Drug Administration (FDA) approved a new screening test for colorectal cancer, commonly referred to as colon cancer. This test is unique because it’s blood-based – meaning no more stool samples or the dreaded colonoscopy. Patients can have the test done as part of their annual blood tests, and they don’t have to think twice about it.
But what it lacks in discomfort it makes up for in inexactitude. This newly approved test is not as sensitive or as accurate as a colonoscopy or as a Fecal Immunochemical Test (FIT), which can detect hidden blood in stool, potentially indicating colon cancer. ...
Source: New Harvard Health Information - July 18, 2016 Category: Consumer Health News Authors: Celia Smoak Spell Tags: Cancer Health Health care Prevention Screening Source Type: news
Immune system blood cell a potential marker for sinus polyp regrowth
In an effort to identify a simple, reliable way to track the course of nasal polyps in chronic sinus disease, researchers say they've linked rising levels of immune system white blood cells, called eosinophils, with regrowth of polyps removed by surgery. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 8, 2016 Category: Science Source Type: news
Immune system blood cell a potential marker for sinus polyp regrowth
(Johns Hopkins Medicine) In an effort to identify a simple, reliable way to track the course of nasal polyps in chronic sinus disease, Johns Hopkins Medicine researchers say they've linked rising levels of immune system white blood cells, called eosinophils, with regrowth of polyps removed by surgery. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2016 Category: Global & Universal Source Type: news
